|
Articles from
October 2009
 |
Myconostica Attains CE Mark for MycAssayTM AspergillusMyconostica Ltd, a UK-based medical diagnostic company which specialises in rapid molecular diagnostic tests for life-threatening fungal infections, today announces the launch of a new test to assist medical and scientific professionals to identify one of the most common causes of fungal pneumonia. |